apomorphine has been researched along with perphenazine in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (62.07) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 5 (17.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jackson, DM | 1 |
| Lassen, JB | 1 |
| Gala, RR; Jaques, S | 1 |
| Dafeldecker, W; Neumeyer, JL; Roffler-Tarlov, S; Schoenfeld, RI | 1 |
| Lotti, VJ | 1 |
| Stille, G | 1 |
| Spoerlein, MT; VanderWende, C | 1 |
| Lehmeyer, JE; MacLeod, RM | 1 |
| Schoenfeld, R; Uretsky, N | 1 |
| Dyntarová, H; Votava, Z | 1 |
| Janssen, PA; Lenaerts, FM; Niemegeers, CJ; Schellekens, KH | 1 |
| Ernst, AM | 1 |
| Haas, H; Jantos, W | 1 |
| Morpurgo, C; Theobald, W | 1 |
| Schelkunov, EL | 1 |
| Dlabac, A; Kazdová, E; Metys, J; Metysová, J; Valchár, M | 1 |
| Zapata, P; Zuazo, A | 1 |
| Kulkarni, SK; Verma, A | 1 |
| Chopra, K; Kulkarni, SK; Raghavendra, V | 1 |
| BHARGAVA, KP; CHANDRA, O | 1 |
1 review(s) available for apomorphine and perphenazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
28 other study(ies) available for apomorphine and perphenazine
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
Topics: Animals; Apomorphine; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Catecholamines; Chlorpromazine; Ditiocarb; Drug Interactions; Haloperidol; Male; Methyltyrosines; Mice; Motor Activity; Neurons; Perphenazine; Phenethylamines; Phenoxybenzamine; Phentolamine; Pimozide; Propranolol; Receptors, Drug; Reserpine | 1975 |
Inhibition of apomorphine-induced hypermotility in rats by chlorpromazine, perphenazine, thioridazine and melperone.
Topics: Animals; Apomorphine; Butyrophenones; Chlorpromazine; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Motor Activity; Perphenazine; Rats; Thioridazine; Time Factors | 1977 |
The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
Topics: Animals; Apomorphine; Bromocriptine; Castration; Ergolines; Female; Humans; Macaca fascicularis; Ovary; Perphenazine; Prolactin; Radioimmunoassay; Thyrotropin-Releasing Hormone; Time Factors | 1975 |
Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat.
Topics: Animals; Apomorphine; Behavior; Catecholamines; Dopamine; Humans; Isomerism; Male; Methyltyrosines; Norepinephrine; Perphenazine; Rats; Stereoisomerism; Stereotyped Behavior | 1975 |
Action of various centrally acting agents in mice with unilateral caudate brain lesions.
Topics: Amphetamine; Animals; Apomorphine; Barbiturates; Catechols; Caudate Nucleus; Central Nervous System; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Dihydroxyphenylalanine; Haloperidol; Hydrazines; Meprobamate; Methyltyrosines; Mice; Pentobarbital; Perphenazine; Posture; Propionates; Pyrrolidines; Reserpine; Synaptic Transmission; Tetrabenazine | 1971 |
[Neuroleptic therapy of schizophrenia from pharmacological viewpoint].
Topics: Animals; Apomorphine; Arousal; Caudate Nucleus; Chlorpromazine; Chlorprothixene; Electroencephalography; Fluphenazine; Haloperidol; Humans; Methotrimeprazine; Perphenazine; Phenothiazines; Promazine; Rats; Reflex; Schizophrenia; Thioridazine; Tranquilizing Agents | 1969 |
Role of dopaminergic receptors in morphine analgesia and tolerance.
Topics: Amantadine; Analgesia; Animals; Apomorphine; Dibenzothiazepines; Dopamine; Drug Synergism; Drug Tolerance; Male; Mice; Mice, Inbred Strains; Morphine; Perphenazine; Phenoxybenzamine; Receptors, Adrenergic; Serine; Spiro Compounds | 1973 |
Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
Topics: Animals; Apomorphine; Bromine; Dopamine; Ergot Alkaloids; Female; Haloperidol; Iodine Radioisotopes; Leucine; Perphenazine; Phentolamine; Pituitary Gland; Prolactin; Propranolol; Radioimmunoassay; Rats; Tritium | 1974 |
Altered response to apomorphine in 6-hydroxydopamine-treated rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Dopamine; Drug Interactions; Injections; Injections, Intraperitoneal; Male; Motor Activity; Norepinephrine; Perphenazine; Rats; Receptors, Adrenergic | 1972 |
Neuropharmacology of apomorphine.
Topics: Amitriptyline; Animals; Apomorphine; Arousal; Behavior, Animal; Benactyzine; Chlorpromazine; Electroencephalography; Imipramine; Nervous System; Perphenazine; Rats | 1970 |
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and
Topics: Acepromazine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benperidol; Chlorpromazine; Chlorprothixene; Fluphenazine; Haloperidol; Male; Mastication; Methods; Motor Activity; Norepinephrine; Perphenazine; Phenothiazines; Prochlorperazine; Promazine; Rats; Thiazines; Thioridazine; Tranquilizing Agents; Trifluoperazine; Triflupromazine; Trimeprazine | 1967 |
The role of biogenic amines in the extra-pyramidal system.
Topics: Animals; Apomorphine; Behavior, Animal; Chemical Phenomena; Chemistry; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Motor Activity; Perphenazine; Rats; Receptors, Drug; Serotonin | 1969 |
[Modification of central mechanisms of action by anticholinergics].
Topics: Aggression; Amphetamine; Animals; Apomorphine; Atropine; Biperiden; Bridged-Ring Compounds; Central Nervous System; Chlorpromazine; Depression, Chemical; Drug Synergism; Esters; Female; Hexobarbital; Humans; Imipramine; Male; Mice; Morphine; Nicotine; Parasympatholytics; Pentylenetetrazole; Perphenazine; Rats; Stimulation, Chemical; Strychnine; Tremorine | 1969 |
Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Body Temperature; Catalepsy; Chlorpromazine; Dextroamphetamine; Dogs; Humans; Mastication; Mice; Movement; Pentobarbital; Perphenazine; Rats; Scopolamine; Trifluoperazine; Trihexyphenidyl; Vomiting | 1964 |
Adrenergic effect of chronic administration of neuroleptics.
Topics: Amphetamine; Animals; Apomorphine; Chlorpromazine; Feedback; Haloperidol; Perphenazine; Rats; Sympathetic Nervous System; Tetrabenazine; Tranquilizing Agents; Trifluoperazine | 1967 |
Pharmacological properties of a potent neuroleptic drug octoclothepin.
Topics: Amphetamines; Animals; Apomorphine; Autonomic Nervous System; Central Nervous System; Chlorpromazine; Depression, Chemical; Dibenzothiepins; Drug Interactions; Locomotion; Male; Mice; Motor Activity; Perphenazine; Rats | 1980 |
Reversal of respiratory responses to dopamine after dopamine antagonists.
Topics: Animals; Apomorphine; Cats; Chlorpromazine; Dopamine; Dopamine Antagonists; Female; Haloperidol; Male; Nitrogen; Oxygen; Perphenazine; Respiration; Spiperone | 1982 |
N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Catalepsy; Dizocilpine Maleate; Haloperidol; Ketamine; Mice; Neuroprotective Agents; Parkinson Disease, Secondary; Perphenazine; Rats; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior | 1995 |
Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan.
Topics: Angiotensin Receptor Antagonists; Animals; Apomorphine; Benzazepines; Catalepsy; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Losartan; Male; Mice; Mice, Inbred BALB C; Motor Activity; Perphenazine; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stereotyped Behavior | 1998 |
ANTI-EMETIC ACTIVITY OF PHENOTHIAZINES IN RELATION TO THEIR CHEMICAL STRUCTURE.
Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Chemistry, Pharmaceutical; Chlorpromazine; Dogs; Perphenazine; Pharmacology; Phenothiazines; Prochlorperazine; Research; Thioridazine; Tranquilizing Agents; Trifluoperazine | 1963 |